exemestane
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
23 FDA-registered drug labelers
Aurobindo Pharma Limited
AX Pharmaceutical Corp
Breckenridge Pharmaceutical, Inc.
Bryant Ranch Prepack
Catalent Micron Technologies, Inc.
Cipla Ltd.
Cipla USA Inc.
Curia Spain S.A.U.
Farmabios S.p.A.
Florida Pharmaceutical Products, LLC
Mylan Pharmaceuticals Inc.
NorthStar Rx LLC
Pfizer Asia Manufacturing Pte Ltd
Pharmacia & Upjohn Company LLC
ScinoPharm Taiwan Ltd.
Shandong Anhong Pharmaceutical Co., Ltd.
Sterling Chemical Malta Ltd
STERLING SPA
Symbiotica Speciality Ingredients Sdn. Bhd.
Upsher-Smith Laboratories, Inc.
Viatris Pharmaceuticals LLC
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Aromasin
- •Exemestane
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS107868-30-4
PubChem CID60198
DTXSIDDTXSID5023037
FormulaC20H24O2
Mol. Weight296.4 g/mol
SMILESCC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
Data Sources
601982026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/exemestane/cids/JSON
Archive: data/sources/pubchem_name/exemestane.json
CAS 107868-30-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json